Varipan Sugar Free Syrup 120 mg/5 mL Syrup
PDF Leaflet Revision Date: 20 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of mild to moderate pain and fever.
Dosage (summary)
Infants: 10 mg/kg (0.41 mL/kg) under 3 months; 2.5-5 mL (60-120 mg) for 3 months to 1 year; Children: 5-10 mL (120-240 mg) for 1-5 years; 10-20 mL (240-480 mg) for 6-12 years.
Onset of Action / Duration
Onset: 30 mins, Duration: 4-6 hours
Special Populations
- Hepatic impairment
- Renal impairment
- Alcohol dependence
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Hepatotoxic medicines
- Warfarin
- Metoclopramide
- Colestyramine
- Salicylates
Contraindications
- Hypersensitivity to paracetamol
- Severe liver function impairment
Common side effects
- Nausea
- Vomiting
- Rash
- Hypersensitivity reactions
Counselling Points
- Do not exceed recommended dose
- Consult if pain or fever persists
- Avoid concurrent use with hepatotoxic drugs
Serious warnings
- Risk of overdose leading to severe liver damage
- Severe cutaneous adverse reactions
Important Disclaimer
The Varipan Sugar Free Syrup 120 mg/5 mL Syrup professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
